nevanac
novartis europharm limited - nepafenac - pain, postoperative; ophthalmologic surgical procedures - oftalmologice - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.
levant 15 mg
terapia s.a. - romania - lansoprazolum - caps. gastrorez. - 15mg - med. pt. trat. ulcerului gastro-duodenal si bolii-reflux g.e inhibitori ai pompei de protoni
levant 30 mg
terapia s.a. - romania - lansoprazolum - caps. gastrorez. - 30mg - med. pt. trat. ulcerului gastro-duodenal si bolii-reflux g.e inhibitori ai pompei de protoni
diovan 3 mg/ml
novartis pharma gmbh - germania - lisinoprilum - sol. orala - 3mg/ml - antagonisti de angiotensina ii antagonisti de angiotensina ii
diovan 40 mg
novartis pharma gmbh - germania - lisinoprilum - compr. film. - 40mg - antagonisti de angiotensina ii antagonisti de angiotensina ii
diovan 160 mg
novartis pharma gmbh - germania - lisinoprilum - compr. film. - 160mg - antagonisti de angiotensina ii antagonisti de angiotensina ii
diovan 80 mg
novartis pharma gmbh - germania - lisinoprilum - compr. film. - 80mg - antagonisti de angiotensina ii antagonisti de angiotensina ii
diovan comprimate filmate 160 mg
novartis pharma ag - lisinoprilum - comprimate filmate - 160 mg
diovan comprimate filmate 80 mg
novartis pharma ag - valsartanum - comprimate filmate - 80 mg
levant 15 mg
ranbaxy (u.k.) limited - lansoprazolum - caps. gastrorez. - 15mg - med. pt. trat. ulcerului gastro-duodenal si bolii-reflux g.e inhibitori ai pompei de protoni